Patient Portal - Flu Reminder Recall

NCT03666026 | Completed Results

• 2 other identifiers: 17-0018891R01AI135029-01
• Study Type: interventional
• Target: 164,205
• Locations: 1 country
• Sites: 1

Brief Summary

This trial is taking place in Los Angeles, CA at clinics within the UCLA Health System. Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low: at 6m-4.9 yrs. (70%), 5-17.9 yrs. (56%), 18-64.9 yrs. (38%), and \>65 yrs. (63%). The investigators will assess the effectiveness and cost-effectiveness of 1, 2, 3 MyChart R/R messages as compared to the standard of care control (no messages).

Conditions

Influenza; Respiratory Tract Infections; Vaccines

Keywords

Reminder Recall (R/R); Influenza Vaccine; Electronic Health Record

Outcome Measures

Primary Outcomes (1)

• 1.Receipt of the Annual Influenza Vaccine (Between 10/1/18 - 4/2/19) Among Index Patients. Outcomes Will be Assessed Via Vaccine Data Extraction From the Electronic Health Record and External Claims and Pharmacy Data.

  Number of participants in each arm who received influenza vaccination

  October 1, 2018 to April 2, 2019 during influenza vaccination season

Study Arms (4)

Standard of care control

NO INTERVENTION

Participants in this group will not receive any MyChart influenza vaccination reminders

1 MyChart R/R

EXPERIMENTAL

Participants in this group will receive up to 1 influenza reminder recall notice via their MyChart account

Behavioral: 1 MyChart R/R

2 MyChart R/R

EXPERIMENTAL

Participants in this group will receive up to 2 influenza reminder recall notices via their MyChart account

Behavioral: 2 MyChart R/R

3 MyChart R/R

EXPERIMENTAL

Participants in this group will receive up to 3 influenza reminder recall notices via their MyChart account

Behavioral: 3 MyChart R/R

Interventions

1 MyChart R/R BEHAVIORAL

Up to 1 flu vaccine reminder recall notice sent via MyChart to patients who are due for the flu vaccine, per the EMR records of the health system.

1 MyChart R/R

2 MyChart R/R BEHAVIORAL

Up to 2 flu vaccine reminder recall notices sent every 3-4 weeks via MyChart to patients who are due for the flu vaccine, per the EMR records of the health system.

2 MyChart R/R

3 MyChart R/R BEHAVIORAL

Up to 3 flu vaccine reminder recall notices sent every 3-4 weeks via MyChart to patients who are due for the flu vaccine, per the EMR records of the health system.

3 MyChart R/R

Eligibility Criteria

• Age: 4 Months+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• A patient within the UCLA Health System identified by the system as a primary care patient per an internal algorithm, with a documented primary care visit within the last 3 years as of 8/1/18.

You may not qualify if:

• A patient not identified by the UCLA Health System's internal algorithm as a primary care patient.

Sponsors & Collaborators

• University of California, Los Angeles: lead
• National Institute of Allergy and Infectious Diseases (NIAID): collaborator

Study Sites (1)

University of California, Los Angeles

Los Angeles, California, 90095, United States

Location

Related Publications (1)

• Szilagyi PG, Albertin C, Casillas A, Valderrama R, Duru OK, Ong MK, Vangala S, Tseng CH, Rand CM, Humiston SG, Evans S, Sloyan M, Lerner C. Effect of Patient Portal Reminders Sent by a Health Care System on Influenza Vaccination Rates: A Randomized Clinical Trial. JAMA Intern Med. 2020 Jul 1;180(7):962-970. doi: 10.1001/jamainternmed.2020.1602.

  PMID: 32421168 DERIVED

MeSH Terms

Conditions

Influenza, Human; Respiratory Tract Infections

Condition Hierarchy (Ancestors)

Infections; Orthomyxoviridae Infections; RNA Virus Infections; Virus Diseases; Respiratory Tract Diseases

Results Point of Contact

• Title: Principal Investigator
• Organization: UCLA

pszilagyi@mednet.ucla.edu

(310) 206-6328

Study Officials

• Peter Szilagyi, MD MPH

  University of California, Los Angeles

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Executive Vice Chair, Clinical Research, UCLA David Geffen School of Medicine, Dept of Pediatrics

Study Record Dates

• First Submitted: September 7, 2018
• First Posted: September 11, 2018
• Study Start: October 2, 2018
• Primary Completion: April 2, 2019
• Study Completion: April 2, 2019
• Last Updated: November 17, 2021
• Results First Posted: November 17, 2021

Record last verified: 2021-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)